LNTH
Lantheus Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$100.55
−0.25%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.25
- Revenue estimate
- $360.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $1.55
- EPS estimate
- $1.30
- Revenue actual
- $388.2M
- Revenue estimate
- $363.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +1.3%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $113
- PT range
- $103 – $129
- Analysts
- 7
3 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $1.30 | $1.55 | Beat 19.23% | $388.2M |
| May 7, 2026 | $1.25 | $1.46 | Beat 16.80% | $377.3M |
| Feb 26, 2026 | $1.18 | $0.82 | Miss -30.85% | $406.8M |
| Nov 6, 2025 | $1.27 | $1.27 | In line | $384.0M |
| Feb 26, 2025 | $1.58 | $1.59 | Beat 0.63% | $391.1M |
| Jul 31, 2024 | $1.83 | $1.80 | Miss -1.91% | $394.1M |
| May 2, 2024 | $1.55 | $1.69 | Beat 8.82% | $370.0M |
| Feb 22, 2024 | $1.47 | $1.75 | Beat 18.81% | $354.0M |
| Nov 2, 2023 | $1.34 | $1.47 | Beat 9.54% | $319.9M |
| Aug 3, 2023 | $1.34 | $1.54 | Beat 14.67% | $321.7M |
| May 4, 2023 | $1.29 | $1.47 | Beat 13.95% | $300.8M |
| Feb 23, 2023 | $0.99 | $1.37 | Beat 38.24% | $263.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026